NeoGenomics
(NASDAQ:NEO)
$13.75
0[0.00%]
At close: Apr 15
$13.75
0[0.00%]
PreMarket: 4:00PM EDT
Q1 2024 Earnings in 14 days from now on Tue Apr 30th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

NeoGenomics Stock (NASDAQ:NEO), Quotes and News Summary

NeoGenomics Stock (NASDAQ: NEO) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 898.763K
Day Range- - -
52 Wk Range11.030 - 21.220
Market Cap$1.755B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest
7.88%
Days to Cover10.12

Recent News

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.
Avi Kapoor
Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith anticipates strong growth, guiding a positive fiscal 2024 outlook with an EPS forecast of $0.04.
Vandana Singh
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
1
Oct 23
1
1
Nov 23
3
Dec 23
3
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Neogenomics Inc.
Sector
Health Care
Industry
Health Care Providers & Services
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United Stat...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NEO
CVS

FAQ

Q

How do I buy NeoGenomics (NEO) stock?

A

You can purchase shares of NeoGenomics (NASDAQ: NEO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeoGenomics's (NEO) competitors?

A

Other companies in NeoGenomics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).

Q

What is the target price for NeoGenomics (NEO) stock?

A

The latest price target for NeoGenomics (NASDAQ: NEO) was reported by Piper Sandler on Monday, February 26, 2024. The analyst firm set a price target for 20.00 expecting NEO to rise to within 12 months (a possible 45.45% upside). 22 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeoGenomics (NEO)?

A

The stock price for NeoGenomics (NASDAQ: NEO) is $13.75 last updated April 15, 2024 at 4:00 PM EDT.

Q

Does NeoGenomics (NEO) pay a dividend?

A

There are no upcoming dividends for NeoGenomics.

Q

When is NeoGenomics (NASDAQ:NEO) reporting earnings?

A

NeoGenomics’s Q1 earnings are confirmed for Tuesday, April 30, 2024.

Q

Is NeoGenomics (NEO) going to split?

A

There is no upcoming split for NeoGenomics.

Q

What sector and industry does NeoGenomics (NEO) operate in?

A

NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

People Also Watch